Epicrania fugax: ten new cases and therapeutic results

Headache
Angel L GuerreroRosa Fernández

Abstract

We aimed to report 10 new cases of epicrania fugax (EF), showing their clinical features and therapeutic responses. Epicrania fugax has been recently described as a paroxysmal head pain starting in a focal area located at a posterior cranial region and rapidly spreading forward to the ipsilateral eye or nose along a linear or zigzag trajectory. In some patients the pain is followed by ocular or nasal autonomic features. In the prior series, 1 patient got pain relief with anesthetic blockades, while another patient improved with carbamazepine. Since the first description of EF, we have assessed 10 patients with the same clinical picture (8 women and 2 men) at the Neurology outpatient offices of our 2 centers. The mean age at onset was 48.5 years (SD: 19.8, range: 23-83). All the patients complained of strictly unilateral pain paroxysms starting at parietal (n = 5), occipital (n = 4), or parieto-occipital locations (n = 1), and immediately spreading forward through a linear pathway toward the ipsilateral forehead (n = 3) or the ipsilateral eye (n = 7), the complete sequence lasting 1-10 seconds. No trigger was identified in any of our patients, while 5 of them suffered mild pain in the stemming area between the paroxysms. Three p...Continue Reading

References

Apr 1, 1996·Cephalalgia : an International Journal of Headache·J A ParejaJ Espejo
Oct 19, 2000·Cephalalgia : an International Journal of Headache·S B Graff-Radford
Oct 12, 2001·Cephalalgia : an International Journal of Headache·M LeandriA Gottlieb
Mar 21, 2002·Acta Neurologica Scandinavica·O SjaastadL S Bakketeig
Jun 6, 2002·Cephalalgia : an International Journal of Headache·J Porta-EtessamJ Benito-Leon
Jun 12, 2002·Neurology·J A ParejaM Sánchez del Río
Jul 12, 2002·Cephalalgia : an International Journal of Headache·H Mariano Da SilvaJ G Speciali
Aug 9, 2002·Headache·Christopher H HuntE Peter Bosch
Mar 15, 2003·Clinical Therapeutics·Miroslav Backonja, Robert L Glanzman
Jun 10, 2004·Headache·Juan A ParejaLydia Vela
Oct 16, 2004·Cephalalgia : an International Journal of Headache·M C FrançaJ A Maciel
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Juan A Pareja, María L Cuadrado
Dec 6, 2005·Headache·Gary L Cohen
Feb 14, 2006·Cephalalgia : an International Journal of Headache·M TruccoG Zanchin
Jul 13, 2006·Current Pain and Headache Reports·Juan A Pareja, Ana B Caminero
Sep 22, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A MayUNKNOWN EFNS Task Force
May 15, 2007·The Journal of Headache and Pain·Marco Trucco
Jan 19, 2008·Cephalalgia : an International Journal of Headache·J A ParejaJ Porta-Etessam
Jan 22, 2008·Headache·Robert Kaniecki
May 6, 2008·Cephalalgia : an International Journal of Headache·W M Mulleners, E P Chronicle
Feb 18, 2009·Cephalalgia : an International Journal of Headache·L C AlvaroE Areitio
Feb 25, 2009·Cephalalgia : an International Journal of Headache·M L CuadradoJ A Pareja

❮ Previous
Next ❯

Citations

May 28, 2011·The Journal of Headache and Pain·Patricia MuleroRosa Fernández
Jun 27, 2014·The Journal of Headache and Pain·Yu WangQing-Qing Pan
May 6, 2014·Current Opinion in Neurology·Dagny Holle, Mark Obermann
Feb 20, 2016·Current Pain and Headache Reports·María Luz CuadradoJuan A Pareja
Apr 10, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Ping Jin, Yu Wang
Jan 3, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Sonia Herrero-VelázquezMaría L Cuadrado
Dec 22, 2011·The Journal of Headache and Pain·Juan A ParejaTeresa Montojo
Apr 9, 2016·SpringerPlus·Ya-Nan LuYu Wang
Oct 30, 2010·Headache·Parul DubeyBhawna Sharma
Apr 12, 2013·Headache·María Luz CuadradoJesús Porta-Etessam
Dec 24, 2014·Headache·María-Luz CuadradoÁngel L Guerrero
Apr 24, 2015·The Journal of Headache and Pain·Yu WangXian-Hong Wang
Jun 23, 2016·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Almudena López-LópezMaría Cuadrado
Sep 9, 2016·Cephalalgia : an International Journal of Headache·Álvaro Gutiérrez-ViedmaMaría-Luz Cuadrado
Oct 25, 2013·European Journal of Orthodontics·M AlqattanS Richmond
Sep 20, 2019·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Yu-Hong ManGang Yao
Nov 7, 2017·Expert Review of Neurotherapeutics·María Luz CuadradoÁngel L Guerrero
Apr 17, 2020·Cephalalgia : an International Journal of Headache·María Gutiérrez-SánchezMaría-Luz Cuadrado
Sep 24, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Michael D PerloffDonna Kurowski
Mar 17, 2021·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Alba Chavarría-MirandaDavid García-Azorín

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cephalalgia : an International Journal of Headache
J A ParejaJesús Porta-Etessam
© 2021 Meta ULC. All rights reserved